Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study
Nicole Lioufas
, Nigel D. Toussaint*
, Eugenia Pedagogos
, Grahame Elder
, Sunil V. Badve
, Elaine Pascoe
, Andrea Valks
, Carmel Hawley
, IMPROVE-CKD Writing Committee
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
Dive into the research topics of 'Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study'. Together they form a unique fingerprint.
Keyphrases
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science